2m 2m 2m 2m 2m 2m 2m
EVOLUS (EOLS)
NASDAQ
$6.43-$0.09 (-1.37%)
Price as of Jul 14, 2026 8:14 AM EDT- $429.4MMarket Cap
- -31.44%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
EVOLUS (EOLS)
$6.43-$0.09 (-1.37%)
EOLS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.52 | ||
Change | -$0.09 (-1.36%) | ||
Open | $6.61 | ||
High | $6.61 | ||
Low | $6.29 | ||
Previous Close | $6.61 | ||
Volume | 1,316,602 | ||
30-Day Average Volume | 828,775 | ||
1-Week Change | -6.72% | ||
1-Month Change | -3.12% | ||
1-Year Change | -31.44% | ||
3-Year Change | -14.21% | ||
5-Year Change | -46.03% | ||
Fundamentals | |||
Shares Outstanding | 65.9M | ||
Total Assets | $220.6M | ||
Market Cap | $429.4M | ||
Enterprise Value | $536.0M | ||
Period: QTR TTM FY | |||
Revenue | $72.7M | ||
Net Income | -$10.7M | ||
Free Cash Flow | -$10.4M | ||
EBIT | -$10.4M | ||
EBITDA | -$8.1M | ||
Net Working Capital | $70.9M | ||
EPS | -$0.16 | ||
Enterprise Value/EBITDA | -66 | ||
Enterprise Value/Revenue | 7 | ||
P/B | -15 | ||
P/E | -41 | ||
PEG | 0 | ||
Price/Free Cash Flow | -41 | ||
Price/Operating Cash Flow | -43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue